RecruitingPhase 1NCT05293197
Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients
Studying Central nervous system embryonal tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Kevin BECCARIA, MD, PhDAssistance Publique - Hôpitaux de Paris
- Intervention
- SonoCloud® (9 transducers)(device)
- Enrollment
- 24 target
- Eligibility
- 5-17 years · All sexes
- Timeline
- 2023 – 2027
Study locations (3)
- Institut Curie, Paris, France
- Service de neurochirugie Pédiatrique - Hôpital Necker- Enfants Malades, Paris, France
- Institut Gustave Roussy, Villejuif, France
Collaborators
CarThera · Gustave Roussy, Cancer Campus, Grand Paris · Institut Curie · URC-CIC Paris Descartes Necker Cochin
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05293197 on ClinicalTrials.govOther trials for Central nervous system embryonal tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07539441A Study of Mirdametinib in People With Central Nervous System TumorsMemorial Sloan Kettering Cancer Center
- RECRUITINGNCT07198256AI-assisted Diagnosis of Malignant Brain TumorsSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGPHASE1NCT05298995GD2-CAR T Cells for Pediatric Brain TumoursBambino Gesù Hospital and Research Institute
- ACTIVE NOT RECRUITINGPHASE1NCT05413304Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral MicrodialysisNational Cancer Institute (NCI)
- RECRUITINGPHASE1, PHASE2NCT05588453Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the BrainKari Kendra
- RECRUITINGNCT05711992Rare Embryonal Tumors of the Central Nervous System: International RegistryImmune Oncology Research Institute
- ACTIVE NOT RECRUITINGPHASE2NCT04074096Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain MetastasisUNICANCER
- RECRUITINGNANCT04181684LITT Followed by Hypofractionated RT for Recurrent GliomasUniversity of Maryland, Baltimore